Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.
about
Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targetsVaccine against autoimmune disease: antigen-specific immunotherapy2011 Update: antigen-specific therapy in type 1 diabetesImmunotherapy of type 1 diabetes: where are we and where should we be going?Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetopeExtra-thymically induced regulatory T cells: do they have potential in disease prevention?Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma.Efforts to prevent and halt autoimmune beta cell destruction.Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline.Treg vaccination with a strong-agonistic insulin mimetope.Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes.Treg vaccination in autoimmune type 1 diabetes.Challenges in the pursuit of immune tolerance.Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Antigen-specific therapeutic approaches in Type 1 diabetesBreakdown in peripheral tolerance in type 1 diabetes in mice and humansT cells in the control of organ-specific autoimmunityMAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD miceA combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.Can we vaccinate against Type 1 diabetes?Prevention of Type 1 Diabetes Mellitus using a Novel Vaccine.Clinical potential of antigen-specific therapies in type 1 diabetes.Altered immune regulation in type 1 diabetes.Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatmentGAD autoantibody epitope pattern after GAD-alum treatment in children and adolescents with type 1 diabetes.Inducing immune tolerance: a focus on Type 1 diabetes mellitus.Type 1 diabetes: etiology, immunology, and therapeutic strategies.T cell recognition of autoantigens in human type 1 diabetes: clinical perspectivesEmerging immune therapies in type 1 diabetes and pancreatic islet transplantation.Trials in type 1 diabetes: Antigen-specific therapies.Progress in immune-based therapies for type 1 diabetes.Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytesAntigen-based vaccination and prevention of type 1 diabetes.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review.Biomarkers for antigen immunotherapy in allergy and type 1 diabetes.
P2860
Q26751244-37B31F7A-D2E2-4B29-A726-A1DA29287AB0Q27028121-A32A67F7-72E1-485F-981A-56FBD655C009Q33593629-D451C0FA-A628-4D59-9D22-A6AF37946DD7Q33815506-92DD5EC2-9588-4791-A0B8-DE276A255CE4Q33937758-0C207F37-2179-40AD-8D4E-D1762EF60F80Q33949282-B604452D-C59F-411F-AC0E-FC28F5642926Q34023585-BB606B8E-861A-47A6-85AE-B98410CE65C6Q34077363-638AB931-CF67-4998-978F-EECC281C5D75Q34227866-5058B401-640A-4C50-80E8-2C19990AB5CDQ34327132-306DFF1C-F9ED-454C-87E6-12945FE3B9F4Q34355286-CBED210F-F0D8-4F27-98A4-5FE27AF3300FQ34375578-40EB50F3-3B55-4B77-823D-1B63372F98C7Q34583970-79B39ADE-8740-402C-80F9-6027127B1C04Q34706913-86580872-BDEC-4F0B-9A00-34EDD1DB4A44Q34957397-4BDEA4FD-91D5-42D0-89FF-AC06AAC80671Q34974448-CB425252-94F7-428F-8368-D73BE5EDA2CFQ35116303-1DB0823D-9DFA-4EAD-9D66-0144102F21CEQ35762883-F43D113C-A81C-4FFA-933D-8CA1A5F1A9B6Q35765731-9EE89562-9C94-40E6-8944-DD42FC9DA7F3Q35836118-962BC781-84C2-46D6-8F75-629398075BC6Q35891738-6B46B6FD-49DF-46E4-B269-9D713AD3A35FQ35960520-92C17948-4F4B-49A3-812A-5A9474E8AC1AQ36011349-FCC3D41A-9FD6-4F20-834E-9D4D3CB7017BQ36296386-4535B459-8C34-4FC7-906D-5ED10ED5EC3FQ36327992-E856B818-117C-4640-B12F-839C335AC112Q37088212-6C4629FF-9610-4293-84B4-8E320247AF47Q37148578-E6AF1CF5-DFCA-427B-914D-D20694C58E4EQ37263111-80BB92D4-569E-46BF-8028-FF7E85C52716Q37520366-1C4EF4A2-6D82-4114-8EAD-D1BAD2CA73C1Q37542678-04C48A2E-AB19-4D72-B744-46B7967CA6A1Q37830198-0C98A5E2-ED74-4CDF-A07C-AF5A0CA70E22Q37904710-650140DB-0783-4C8F-959F-5B1416275F65Q38063547-15B97BF7-4748-467B-839B-6DD5507518ECQ38089387-43791F22-AC00-486A-9AC9-AF8359D0835EQ38097920-A7F7D732-329B-4119-89C8-63909F29D1C7Q38117282-FB12ED68-8AF1-4C15-9808-1B312DAF8900Q38124273-F02919FC-529E-4C8B-8B09-80F8486AF98CQ38135862-BC244FB4-69DC-48AE-A18E-4681CCFB56E5Q38236300-8635C8E0-7D99-460C-BCF5-210B916D7CFAQ38539950-4B3856B3-9B8C-41EB-9665-E5703FB42D04
P2860
Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Autoantigen-specific regulator ...... insulin B-chain immunotherapy.
@ast
Autoantigen-specific regulator ...... insulin B-chain immunotherapy.
@en
type
label
Autoantigen-specific regulator ...... insulin B-chain immunotherapy.
@ast
Autoantigen-specific regulator ...... insulin B-chain immunotherapy.
@en
prefLabel
Autoantigen-specific regulator ...... insulin B-chain immunotherapy.
@ast
Autoantigen-specific regulator ...... insulin B-chain immunotherapy.
@en
P2093
P2860
P921
P1476
Autoantigen-specific regulator ...... insulin B-chain immunotherapy.
@en
P2093
Alyne Ricker
Andras Treszl
Helena Reijonen
Heyam Jalahej
Jeffrey B Matthews
Joseph Wolfsdorf
Klara Farkas
Nadio Tchao
P2860
P304
P356
10.1016/J.JAUT.2009.10.005
P577
2010-06-01T00:00:00Z